Bacterial meningitis: Complement gene expression in the central nervous system

Immunopharmacology

Volumn 38, Issue 1-2, 1997, Pages 65-72

  Stahel, Philip F ^a   Barnum, Scott R ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Bacterial meningitis; Central nervous system; Complement; Neurons

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5A; COMPLEMENT RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BACTERIAL MENINGITIS; BLOOD BRAIN BARRIER; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HUMAN; INFLAMMATION; LEUKOCYTE; LISTERIA MONOCYTOGENES; MOUSE; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0031443978     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(97)80150-6     Document Type: Review

References (58)

1. Ahmed, A.A., Salih, M.A.M., Ahmed, H.S., 1996. Post-endemic acute bacterial meningitis in Sudanese children. East Afr. J. 73, 527-532.
2. Barnum, S.R., 1995. Complement biosynthesis in the central nervous system. Crit. Rev. Oral Biol. Med. 6, 132-146.
3. Bellander, B.-M., von Holst, H., Fredman, P., Svensson, M., 1996. Activation of the complement cascade and increase of clusterin in the brain following a cortical contusion in the adult rat. J. Neurosurg. 85, 468-475.
4. Buchanan, N., MacNab, G., 1972. Cerebrospinal fluid complement and immunoglobulins in meningitis and encephalitis. S. Afr. Med. J. 46, 1376-1382.
5. Davis, W.D., Brey, R.L., 1992. Antiphospholipid antibodies and complement activation in patients with cerebral ischemia. Clin. Exp. Rheumatol. 10, 455-460.
6. Durand, M.L., Calderwood, S.B., Weber, D.J., Miller, S.I., Southwick, F.S., Caviness Jr, V.S., Swartz, M.N., 1993. Acute bacterial meningitis in adults: a review of 493 episodes. N. Engl. J. Med. 328, 21-28.
7. Ernst, J.D., Hartiala, K.T., Goldstein, I.M., Sande, A.M., 1984. Complement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis. Infect. Immun. 46, 81-86.
8. Faustmann, P.M., Krause, D., Dux, R., Dermietzel, R., 1995. Morphological study in the early stages of complement C5a fragment-induced experimental meningitis: activation of macrophages and astrocytes. Acta Neuropathol. 89, 239-247.
9. Finland, M., Brown, J.W., Rauh, A.E., 1938. Treatment of pneumococcic meningitis. A study of ten cases treated with sulfanilamide alone or in various combinations with specific antipneumococcic serum and complement, including six recoveries. N. Engl. J. Med. 218, 1033-1044.
10. Fishman, R.A., Sligar, K., Hake, R.B., 1977. Effects of leukocytes on brain metabolism in granulocytic brain edema. Ann. Neurol. 2, 89-94.
11. Fothergill, L.D., Wright, J., 1932. Influenzal meningitis. The relation of age incidence to the bactericidal power of blood against causal organism. J. Immunol. 24, 273-284.
12. Fothergill, L.D., 1935. Observations on the presence of complement in the cerebrospinal fluid in various pathologic conditions of the central nervous system. J. Pediatr. 6, 374-381.
13. Fothergill, L.D., 1937. Haemophilus influenzae (Pfeiffer bacillus) meningitis and its specific treatment. N. Engl. J. Med. 216, 587-590.
14. Frei, K., Fontana, A., 1989. Immune regulatory functions of astrocytes and microglial cells within the central nervous system. In: Goetzl, E.J., Spector, N.H. (Eds.), Neuroimmune Networks: Physiology and Diseases. Alan R. Liss, New York, pp. 127-136.
15. Gasque, P., Chan, P., Fontaine, M., Ischenko, A., Lamacz, M., Götze, O., Morgan, B.P., 1995. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155, 4882-4889.
16. Gerard, C., Gerard, N.P., 1994. C5a anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12, 775-808.
17. Hoen, B., Viel, J.F., Paquot, C., Gérard, A., Canton, P., 1995. Multivariate approach to differential diagnosis of acute meningitis. Eur. J. Clin. Microbiol. Infect. Dis. 14, 267-274.
18. Hoffmann, T.A., Edwards, E.A., 1972. Group-specific polysaccharide antigen and humoral antibody response in disease due to Neisseria meningitidis. J. Infect. Dis. 126, 636-644.
19. Kaczorowski, S.L., Schiding, J.K., Toth, C.A., Kochanek, P.M., 1995. Effect of soluble complement receptor-1 on neutrophil accumulation after traumatic brain injury in rats. J. Cereb. Blood Flow Metab. 15, 860-864.
20. Kadurugamuwa, J.L., Hengstler, B., Bray, M.A., Zak, O., 1989. Inhibition of complement-factor-5a-induced inflammatory reactions by prostaglandin E2 in experimental meningitis. J. Infect. Dis. 160, 715-719.
21. Kasuya, H., Shimizu, T., 1989. Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage. J. Neurosurg. 71, 741-746.
22. Kossmann, T., Stahel, P.F., Morganti-Kossmann, M.C., Jones, J.L., Barnum, S.R., 1997. Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injury. J. Neuroimmunol. 73, 63-69.
23. Lacy, M., Jones, J., Whittemore, S.R., Haviland, D.L., Wetsel, R.A., Barnum, S.R., 1995. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and F.M.L.P. by human astrocytes and microglia. J. Neuroimmunol. 61, 71-78.
24. Leist, T.P., Frei, K., Kam-Hansen, S., Zinkernagel, R.M., Fontana, A., 1988. Tumor necrosis factor α in cerebrospinal fluid during bacterial but not viral meningitis. Evaluation in murine model infection and in patients. J. Exp. Med. 167, 1743-1748.
25. Lindquist, L., Linné, T., Hansson, L.-O., Kalin, M., Axelsson, G., 1988. Value of cerebrospinal fluid analysis in the differential diagnosis of meningitis: a study in 710 patients with suspected central nervous system infection. Eur. J. Clin. Microbiol. Infect. Dis. 7, 374-380.
26. Lindsberg, P.J., Ohman, J., Lehto, T., Karjalainen-Lindsberg, M.-L., Paetau, A., Wuorimaa, T., Carpén, O., Kaste, M., Meri, S., 1996. Complement activation in the central nervous system following blood-brain barrier damage in man. Ann. Neurol. 40, 587-596.
27. Morgan, B.P., Gasque, P., 1996. Expression of complement in the brain: role in health and disease. Immunol. Today 17, 461-466.
28. Müller-Ladner, U., Jones, J.L., Wetsel, R.A., Gay, S., Raine, C., Barnum, S.R., 1996. Enhanced expression of chemotactic receptors in multiple sclerosis lesions. J. Neurol. Sci. 144, 135-141.
29. Murphy, P.M., 1994. The molecular biology of leukocyte chemo-attractant receptors. Annu. Rev. Immunol. 12, 593-633.
30. Mustafa, M.M., Ramilo, O., Olsen, K.D., Franklin, P.S., Hansen, E.J., Beutler, B., McCracken Jr, G.H., 1989. Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis. J. Clin. Invest. 84, 1253-1259.
31. Nadal, D., Leppert, D., Frei, K., Gallo, P., Lamche, H., Fontana, A., 1989. Tumour necrosis factor-α in infectious meningitis. Arch. Dis. Child. 64, 1274-1279.
32. Nolan, C.M., Clark, R.A., Beaty, H.N., 1975. Experimental pneumococcal meniningitis. III. Chemotactic activity in cerebrospinal fluid. Proc. Soc. Exp. Biol. Med. 150, 134-136.
33. Pfister, H.-W., Fontana, A., Täuber, M.G., Tomasz, A., Scheld, W.M., 1994. Mechanisms of brain injury in bacterial meningitis: workshop summary. Clin. Infect. Dis. 19, 463-479.
34. Quagliarello, V., Scheld, W.M., 1992. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N. Engl. J. Med. 327, 864-872.
35. Quagliarello, V.J., Scheld, W.M., 1997. Treatment of bacterial meningitis. N. Engl. J. Med. 336, 708-716.
36. Ramilo, O., Saez-Llorens, X., Mertsola, J., Jafari, H., Olsen, K.D., Hansen, E.J., Yoshinaga, M., Ohkawara, S., Nariuchi, H., McCracken, G.H. Jr., 1990. Tumor necrosis factor α/cachectin and interleukin 1β initiate meningeal inflammation. J. Exp. Med. 172, 497-507.
37. Rapoport, S.I., 1976. Blood-Brain Barrier in Physiology and Medicine. Raven Press, New York.
38. Rodewald, L.E., Woodin, K.A., Szilagyi, P.G., Arvan, D.A., Raubertas, R.F., Powell, K.R., 1991. Relevance of common tests of cerebrospinal fluid in screening for bacterial meningitis. J. Pediatr. 119, 363-369.
39. Saez-Llorens, X., Jafari, H.S., Severien, C., Parras, F., Olsen, K.D., Hansen, E.J., Singer, I.I., McCracken Jr, G.H., 1991. Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis. J. Clin. Invest. 88, 2003-2011.
40. Saukkonen, K., Sande, S., Cioffe, C., Wolpe, S., Sherry, B., Cerami, A., Tuomanen, E., 1990. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J. Exp. Med. 171, 439-448.
41. Segreti, J., Harris, A.A., 1996. Acute bacterial meningitis. Infect. Dis. Clin. North America 10, 797-809.
42. Spicer, S., Appelbaum, E., Rutstein, D.D., 1949. Complement and its component fractions in cerebrospinal fluid in inflammatory cerebrospinal diseases. J. Clin. Invest. 28, 389-393.
43. Spiegel, K., Emmerling, M., Barnum, S.R., 1997. Acute phase proteins: strategies for inhibition of complement activation in the treatment of neurodegenerative diseases. In: Woods, P. (Ed.), Inflammatory Mechanisms and Management of Neurodegeneration. Humana Press, Totowa, NJ, in press.
44. Stahel, P.F., Frei, K., Eugster, H.-P., Fontana, A., Hummel, K.M., Wetsel, R.A., Ames, R.S., Barnum, S.R., 1997a. TNF-α-mediated expression of the receptor for anaphylatoxin C5a on neuron in experimental Listeria meningoencephalitis. J. Immunol. 159, 861-869.
45. Stahel, P.F., Nadal, D., Pfister, H.-W., Paradisis, P.M., Fontana, A., Barnum, S.R., 1997b. Complement C3 and factor B cerebrospinal fluid levels discriminate bacterial from aseptic meningitis. Lancet 349, 1886.
46. Tang, T., Frenette, P.S., Hynes, R.O., Wagner, D.D., Mayadas, T.N., 1996. Cytokine-induced meningitis is dramatically attenuated in mice deficient in endothelial selectins. J. Clin. Invest. 97, 2485-2490.
47. Täuber, M.G., Borschberg, U., Sande, M.A., 1988. Influence of granulocytes on brain edema, intracranial pressure, and cerebrospinal fluid concentrations of lactate and protein in experimental meningitis. J. Infect. Dis. 157, 456-464.
48. Törnqvist, E., Liu, L., Aldskogius, H., von Holst, H., Svensson, M., 1996. Complement and clusterin in the injured nervous system. Neurobiol. Aging 17, 695-705.
49. Townsend, G.C., Scheld, W.M., 1993. Adjunctive therapy for bacterial meningitis: rationale for use, current status, and prospects for the future. Clin. Infect. Dis. 17 (Suppl. 2), S537-S549.
50. Tunkel, A.R., Scheld, W.M., 1995. Acute bacterial meningitis. Lancet 346, 1675-1680.
51. Tuomanen, E., Hengstler, B., Zak, O., Tomasz, A., 1986. The role of complement in inflammation during experimental pneumococcal meningitis. Microb. Pathog. 1, 15-32.
52. Tuomanen, E.I., Saukkonen, K., Sande, S., Cioffe, C., Wright, S.D., 1989. Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J. Exp. Med. 170, 959-968.
53. Waage, A., Halstensen, A., Shalaby, R., Brandtzaeg, P., Kierulf, P., Espevik, T., 1989. Local production of tumor necrosis factor α, interleukin 1, and interleukin 6 in meningococcal meningitis: relation to the inflammatory response. J. Exp. Med. 170, 1859-1867.
54. Weiss, S.J., 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320, 365-376.
55. Wetsel, R.A., 1995. Structure, function and cellular expression of complement anaphylatoxin receptors. Curr. Opin. Immunol. 7, 48-53.
56. Whittle, H.C., Greenwood, B.M., 1977. Cerebrospinal fluid immunoglobulins and complement in meningococcal meningitis. J. Clin. Pathol. 30, 720-722.
57. Williams, C.A., Schupf, N., Hugh, T.E., 1985. Anaphylatoxin C5a modulation of an alpha-adrenergic receptor system in the rat hypothalamus. J. Neuroimmunol. 9, 29-40.
58. Zwahlen, A., Nydegger, U.E., Vaudaux, P., Lambert P.-H., Waldvogel, F.A., 1982. Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis. J. Infect. Dis. 145, 635-646.